Peking University, March 22: On March 4, CPPCC member and Vice President of Peking University First Hospital Ding Jie commented on the difficulty of rare disease treatment, large economic burden and lack of rare disease medicine. She suggested to establish a rare disease health security system, gradually completing medicine catalogue and adding rare disease medicine, reagent and related equipment into the social medical insurance range in batches.
Considering departments of pediatrics are consistently making losses, Ding Jie proposed an increase in the charge for children’s diagnosis and treatment and a particular compensation system. The added expense could be covered by enlarging the medical insurance range, raising the refund ratio and other measures. Ding Jie emphasized that children are an essential group in the construction of a healthy China, and pediatricians, as the guardian of children, deserve better care and respect.
CPPCC member and Assistant Director of Peking University Health Science Center Wu Ming pointed out that China, at present, adopts the policy which retirees enjoy free medical services through in employee social medical insurance. With the aging of population and an increase in life expectancy, the proportion of staff on active duty, who pay for medical services, will be lower and lower. In response, future medical insurance fund burdens will be much heavier. To solve this problem, Wu Ming suggested that on one hand, retirees should pay a certain part of medical insurance. On the other hand, more approaches could be taken to raise money. Besides, hospitals, on the premise of guaranteed quality, should actively control cost, raise efficiency by strengthening fund monitoring.
At present, screening of hypertension and diabetes management has been included in China’s public healthcare system except blood lipid management. CPPCC member and Director of Peking University First Hospital Internal Medicine, Professor Huo Yong commented on this situation in the past few days. He said the cardiovascular disease morbidity is still on the rise and appealed to the government to include blood lipid management in public healthcare system. “Only in this way could we actually control the morbidity and death rate of cardiovascular disease in general.”
Recently, CPPCC member and president of Peking University International Hospital Chen Zhongqiang said that, with the help of the Internet, mobile health has become an important support for the current healthcare system. But to most mobile health enterprises, what matters is the actual implementation rather than online ordering or patterns of payment in treatment process.
According to Chen, most mobile health platforms are not actually performing real deeds. They can be a strong support instead of a substitution in modern treatment service for face-to-face diagnosis between doctors and patients could not be replaced. In this way, mobile health still has a large space for development in terms of raising treatment efficiency.
Written by: Fu Guirong
Edited by: Xu Liangdi
